Rho-kinase Activity in Circulating Leukocytes as a Novel Biomarker of Heart Failure

Heart failure (HF) is a complex clinical syndrome, where both HF with preserved ejection fraction (HFpEF) and HF with reduced EF (HFrEF) are substantially involved. In this study, we examined whether Rho-kinase is activated in HF patients.